Lapsed Jun 10, 2026 on the fee record · High confidence
20-year base term ends Apr 30, 2028
Third maintenance fee unpaid; grace period ended.
Held by Concert Pharmaceuticals Inc.
Filed Jul 24, 2013 as application 13/949,499 · Granted Jun 10, 2014
Base term, 20 years from filing
Today
Lapsed Jun 10, 2026
2008
2028
Clock starts
Apr 30, 2008
Apr 30, 2008
No longer in force
Jun 10, 2026
Jun 10, 2026
Granted
Jun 10, 2014
Jun 10, 2014
Term would have run to
Apr 30, 2028
Apr 30, 2028
base term
after the term ends
fee events
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,973,049, US 8,188,110, to Apr 30, 2028. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
Its term would have run to Apr 30, 2028: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 30, 2008, when application 12/112,936, the earliest non-provisional in its chain, was filed (this one was filed Jul 24, 2013) | Apr 30, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,973,049, US 8,188,110) | resolves to Apr 30, 2028, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Jun 10, 2026 | High confidence |
| Computed term end | The steps above, in order | Jun 10, 2026 | High confidence |
This family
| US 7,973,049 | In force Apr 2030 | Apr 2030 |
| US 8,188,110 | In force Apr 2028 | Apr 2028 |
| US 8,541,436 | In force Apr 2028 | Apr 2028 |
| US 8,748,450 | this patent Jun 2026 | Jun 2026 |
| US 9,072,711 | In force Apr 2028 | Apr 2028 |
| US 9,314,440 | In force Apr 2028 | Apr 2028 |
| US 9,868,976 | In force Apr 2028 | Apr 2028 |
| Application 15/839,387 | Abandoned not computed | not computed |
8 of 11 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 29, 2013 Reel 30897, frame 702 | Tung, Roger | Concert Pharmaceuticals Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,973,049, US 8,188,110, ends no earlier than this term, so it caps nothing.
Citations
8
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.